Disease-free survival as a surrogate for overall survival in HR+/HER2- early breast cancer: A correlation analysis.
Saved in:
| Title: | Disease-free survival as a surrogate for overall survival in HR+/HER2- early breast cancer: A correlation analysis. |
|---|---|
| Authors: | Untch M; Interdisciplinary Breast Cancer Center, Helios Klinikum Berlin-Buch, Berlin, Germany. Electronic address: michael.untch@helios-gesundheit.de., Pérol D; Centre Léon Bérard, Lyon, France., Mayer EL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Cortes J; International Breast Cancer Center (IBCC), Grupo Quiron, Madrid & Barcelona, Spain., Nusch A; Practice for Hematology and Internal Oncology, Velbert, Germany., Cameron D; Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, UK., Barrios C; Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil., Delea T; Policy Analysis Inc. (PAI), Boston, MA, USA., Danyliv A; Novartis Pharma AG, Basel, Switzerland., Mishra N; Novartis Healthcare Pvt Ltd, Hyderabad, India., Gupta R; Novartis Healthcare Pvt Ltd, Hyderabad, India., Pathak P; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Fasching PA; University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany. |
| Source: | European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 May; Vol. 202, pp. 113977. Date of Electronic Publication: 2024 Mar 01. |
| Publication Type: | Systematic Review; Journal Article |
| Journal Info: | Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
